REAL-WORLD TREATMENT PATTERNS OF OMALIZUMAB IN CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA (CIU/CSU) PATIENTS IN THE UNITED STATES

被引：0
|
作者：
Eghrari-Sabet, J.
Sher, E.
Lefebvre, P.
Pilon, D.
Zhdanava, M.
Balp, M.
Kavati, A.
Ortiz, B.
Bernstein, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2017年 / 119卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P162
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [21] Real-World Survey Outcomes For Chronic Spontaneous Urticaria For Patients On Omalizumab Versus Patients Eligible For Omalizumab
    Holden, Michael
    Bernstein, Jonathan
    Seetasith, Arpamas
    Garmo, Vincent
    Hetherington, James
    Hoskin, Ben
    Wrest, Eleanor
    Casale, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB187 - AB187
  • [22] Efficacy and safety of omalizumab in Japanese and Korean patients with chronic spontaneous/idiopathic urticaria (CSU/CIU): Results from the phase III POLARIS study
    Hide, Michihiro
    Park, Hae-Sim
    Igarashi, Atsuyuki
    Ye, Young Min
    Kim, Tae-Bum
    Yagami, Akiko
    Lee, Jae-Hyun
    Fukunaga, Atsushi
    Khalil, Sam
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB112 - AB112
  • [23] Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of "real-world' evidence
    Bernstein, Jonathan A.
    Kavati, Abhishek
    Tharp, Michael D.
    Ortiz, Benjamin
    MacDonald, Karen
    Denhaerynck, Kris
    Abraham, Ivo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (04) : 425 - 448
  • [24] Successful treatment of chronic idiopathic urticaria & Angioedema (CIU), with Xolair (omalizumab)
    Shapiro, C. A.
    Kapetanos, N. S.
    Sarmiento, E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S274 - S274
  • [25] Omalizumab on Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Real-World Study of Efficacy and Predictors of Treatment Outcome
    Jeong, Soo Hyun
    Lim, Dong Jun
    Chang, Sung Eun
    Kim, Kwang Ho
    Kim, Kwang Joong
    Park, Eun Joo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (27)
  • [26] Omalizumab for severe chronic spontaneous urticaria (CSU)-real life experience of 251 patients
    Vadasz, Z.
    Asher, I
    Tal, Y.
    Rotem, M.
    Shichter-Confino, V
    Greif, Y.
    Kessel, A.
    Agmon-Levin, N.
    Benor, S.
    Lachover-Roth, I
    Zeldin, Y.
    Stein, M.
    Toker, O.
    Mahlab-Guri, K.
    Bezalel-Rosenberg, S.
    Hassoun, J.
    Toubi, E.
    Sthoeger, Z.
    ALLERGY, 2017, 72 : 716 - 716
  • [27] OMALIZUMAB TREATMENT OF CHRONIC SPONTANEOUS URTICARIA: EFFECTIVENESS AND SATISFACTION ASSESSED BY A REAL-WORLD SURVEY
    Casale, T.
    Seetasith, A.
    Hetherington, J.
    Hoskin, B.
    Wrest, E.
    Garmo, V.
    Holden, M.
    Bernstein, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S27 - S27
  • [28] A retrospective analysis of omalizumab treatment in patients with chronic spontaneous urticaria. A real-world study in Spain
    Laiseca, Garcia J.
    Gonzalez, Bravo L.
    Perez, Fernandez E.
    Perez, Codesido S.
    Privitera, Torres M.
    Brandoni, Petrone M. M.
    Tejedor, Alonso M. A.
    Rosado, Ingelmo A.
    ALLERGY, 2020, 75 : 324 - 325
  • [29] OMALIZUMAB TREATMENT IS EFFECTIVE FOR PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA DESPITE DELAY IN TREATMENT INITIATION: A REAL-WORLD STUDY
    Rajput, Y.
    Thomas, C.
    Hetherington, J.
    Hoskin, B.
    Wrest, E.
    Holden, M.
    Bernstein, J. A.
    VALUE IN HEALTH, 2022, 25 (07) : S587 - S587
  • [30] Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
    Maurer, Marcus
    Rosen, Karin
    Hsieh, Hsin-Ju
    Saini, Sarbjit
    Grattan, Clive
    Gimenez-Arnau, Ana
    Agarwal, Sunil
    Doyle, Ramona
    Canvin, Janice
    Kaplan, Allen
    Casale, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10): : 924 - 935
12345